Algo version: 0.98b
PIRS is listed at the NASDAQ Exchange
PIRS [PIRS]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is PIRS stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Pieris Pharmaceuticals 10 years ago, but if you had invested on Friday 2nd of January 2015 when the price was $2.75, you would have made a profit of $13.26 per share or 482.18%

Yes, the average daily trading liquidity for Pieris Pharmaceuticals is $1.42 million. You should therefore be able to get in and out of your positions relatively fast.

Pieris Pharmaceuticals has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Pieris Pharmaceuticals to be medium [0.7 out of 1]